Differentiation of imatinib -resistant chronic myeloid leukemia cells with BCR-ABL-T315I mutation induced by Jiyuan Oridonin A

Chronic myeloid leukemia (CML) results from BCR-ABL oncogene, which blocks CML cells differentiation and protects these cells from apoptosis. T315I mutated BCR-ABL is the main cause of the resistance mediated by imatinib and second generation BCR-ABL inhibitor. CML with the T315I mutation has been c...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yun, Wang, Ziting, Zhang, Lei, Gao, Congying, Li, Fahui, Li, Xueming, Ke, Yu, Liu, Hong-Min, Hu, Zhenbo, Wei, Liuya, Chen, Zhe-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197941/
https://www.ncbi.nlm.nih.gov/pubmed/37215441
http://dx.doi.org/10.7150/jca.83219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197941/
https://www.ncbi.nlm.nih.gov/pubmed/37215441
http://dx.doi.org/10.7150/jca.83219

Ejemplares similares